Damian J. Green, M.D., is a physician scientist and Associate Member in the Clinical Research Division at Fred Hutch with a joint appointment as Associate Professor at the University of Washington. He is also the Deputy Director for Multiple Myeloma of the Seattle Translational Tumor Registry. His research laboratory focuses on the development of novel immunotherapy-based approaches to the treatment of multiple myeloma and other B cell malignancies. Dr. Green’s training, under the careful stewardship of the late Dr. Oliver Press, prepared him for the combined responsibilities of patient care, laboratory-based discovery and translational clinical implementation of his research. In the clinic, he sees patients with multiple myeloma, performs bone marrow transplants and manages patients receiving chimeric antigen receptor (CAR) T cells and other forms of immunotherapy. He is currently the lead investigator on three major independent federal research grants (2 R01; 1 PPG) and is Principal Investigator on five active clinical trials. He collaborates very closely with Dr. Stan Riddell in the development and refinement of CAR T cells for multiple myeloma. Dr. Green also maintains a multiple myeloma biospecimen bank with over 1000 specimens and linked clinical data. He was recently named a Next Generation Innovator in Hematology/Oncology and a recipient of an Immunotherapy Innovator Award. Dr. Green and his team seek to elucidate mechanisms of tumor resistance to therapy and to identify approaches that will eradicate currently incurable cancers of the blood and bone marrow.